TuHURA Biosciences, Inc. (HURA)
2.05
-0.08
(-3.76%)
USD |
NASDAQ |
Sep 23, 16:00
2.05
0.00 (0.00%)
Pre-Market: 09:08
TuHURA Biosciences Shareholders Equity (Quarterly) : 18.50M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.50M |
| March 31, 2026 | 23.19M |
| December 31, 2025 | 20.93M |
| September 30, 2025 | 16.78M |
| June 30, 2025 | 19.45M |
| March 31, 2025 | 9.856M |
| December 31, 2024 | 14.59M |
| September 30, 2024 | -2.767M |
| June 30, 2024 | 3.757M |
| March 31, 2024 | 5.922M |
| December 31, 2023 | -0.164M |
| September 30, 2023 | -2.026M |
| June 30, 2023 | 0.731M |
| March 31, 2023 | 3.786M |
| December 31, 2022 | 6.598M |
| September 30, 2022 | 9.618M |
| June 30, 2022 | 11.80M |
| March 31, 2022 | 9.386M |
| December 31, 2021 | 14.10M |
| September 30, 2021 | 19.16M |
| June 30, 2021 | 10.58M |
| March 31, 2021 | 16.12M |
| December 31, 2020 | 17.58M |
| September 30, 2020 | 20.55M |
| June 30, 2020 | 0.263M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.720M |
| December 31, 2019 | 5.481M |
| September 30, 2019 | 7.025M |
| June 30, 2019 | 1.968M |
| March 31, 2019 | 1.259M |
| December 31, 2018 | 2.769M |
| September 30, 2018 | 3.670M |
| June 30, 2018 | 5.435M |
| March 31, 2018 | 7.660M |
| December 31, 2017 | 9.984M |
| September 30, 2017 | 12.92M |
| June 30, 2017 | 6.578M |
| March 31, 2017 | 1.230M |
| December 31, 2016 | 2.702M |
| September 30, 2016 | 3.974M |
| June 30, 2016 | 4.859M |
| March 31, 2016 | -0.6876M |
| December 31, 2015 | 0.1167M |
| September 30, 2015 | -0.5145M |
| June 30, 2015 | -0.8215M |
| March 31, 2015 | 1.217M |
| December 31, 2014 | 2.087M |
| September 30, 2014 | 0.5209M |
| June 30, 2014 | -0.9012M |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 31.75M |
| Total Liabilities (Quarterly) | 13.25M |
| Debt to Equity Ratio | 0.2166 |
| Current Ratio | 0.1789 |
| Net Debt Paydown Yield | -0.52% |